[Chinese guidelines on the treatment of hemophilia (version 2020)].
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2020 Apr 14;41(4):265-271. doi: 10.3760/cma.j.issn.0253-2727.2020.04.001.
Abstract
摘要
相似文献
1
[Chinese guidelines on the treatment of hemophilia (version 2020)].[中国血友病治疗指南（2020年版）]
Zhonghua Xue Ye Xue Za Zhi. 2020 Apr 14;41(4):265-271. doi: 10.3760/cma.j.issn.0253-2727.2020.04.001.
2
Hemophilia.血友病
Indian Pediatr. 2000 Jan;37(1):45-53.
3
Guidelines for management of hemophilia A and B.甲型和乙型血友病管理指南。
Blood. 1995 Jan 15;85(2):598-9.
4
Pioneering therapeutic proteins in hemophilia care through innovative technologies.通过创新技术开创血友病治疗中的治疗性蛋白质疗法。
Thromb Res. 2016 May;141 Suppl 3:S1. doi: 10.1016/S0049-3848(16)30413-3.
5
[Treatment of hemophilia].[血友病的治疗]
Tidsskr Nor Laegeforen. 1970 Jul 1;90(13):1413-8.
6
[Hemophilia].[血友病]
Rinsho Ketsueki. 2013 Feb;54(2):189-97.
7
Status of gene transfer for hemophilia A and B.甲型和乙型血友病的基因转移现状。
Thromb Haemost. 1991 Jul 12;66(1):119-22.
8
[Experiences from the Hemophilia Clinic. II].[血友病诊所的经验。II]
Ned Tijdschr Geneeskd. 1968 Jul 27;112(30):1372-7.
9
[Recent advance in hemophilia therapy (2): gene and cell therapy for hemophilia].血友病治疗的最新进展（2）：血友病的基因治疗和细胞治疗
Rinsho Ketsueki. 2014 Aug;55(8):899-907.
10
[New viewpoints in the treatment of hemophilia].[血友病治疗的新观点]
Dtsch Med Wochenschr. 1973 Sep 28;98(39):1814-6. doi: 10.1055/s-0028-1107135.
引用本文的文献
1
Assessing the health-state utility values of rare disease-hemophilia B using EQ-5D-5L: a study based on the Chinese population.使用EQ-5D-5L评估罕见病——乙型血友病的健康状态效用值：一项基于中国人群的研究。
Orphanet J Rare Dis. 2025 Aug 7;20(1):407. doi: 10.1186/s13023-025-03894-y.
2
The effect of prophylactic FVIII infusion combined with personalized rehabilitation on joint health and quality of life in children with hemophilia.预防性输注凝血因子VIII联合个性化康复对血友病儿童关节健康和生活质量的影响。
Front Pediatr. 2025 Jul 10;13:1578617. doi: 10.3389/fped.2025.1578617. eCollection 2025.
3
Global trends in hemophilic arthropathy research: a bibliometric and visualization analysis.血友病性关节病研究的全球趋势：文献计量与可视化分析
Front Med (Lausanne). 2025 Apr 16;12:1556906. doi: 10.3389/fmed.2025.1556906. eCollection 2025.
4
Sequential combined bypassing therapy in haemophilia patients with high titer inhibitors: surgical experience.高滴度抑制物血友病患者的序贯联合旁路治疗：手术经验
Ann Hematol. 2025 Mar;104(3):1949-1960. doi: 10.1007/s00277-025-06265-6. Epub 2025 Feb 26.
5
Clinical analysis and quality of life survey of hemophilia B patients in the central and western regions of China.中国中西部地区乙型血友病患者的临床分析与生活质量调查
Front Pediatr. 2024 May 9;12:1366990. doi: 10.3389/fped.2024.1366990. eCollection 2024.
6
Urgent-start peritoneal dialysis in the hemophilia a patient with chronic kidney disease: A case report.血友病 A 合并慢性肾脏病患者的紧急启动腹膜透析：一例报告
Clin Case Rep. 2023 Sep 7;11(9):e7659. doi: 10.1002/ccr3.7659. eCollection 2023 Sep.
7
Quantifying Benefit-Risk Trade-Offs Toward Prophylactic Treatment Among Adult Patients With Hemophilia A in China: Discrete Choice Experiment Study.定量评估中国成人甲型血友病患者预防性治疗的获益-风险权衡：离散选择实验研究。
JMIR Public Health Surveill. 2023 Jul 26;9:e45747. doi: 10.2196/45747.
8
Total knee arthroplasty and femoral osteotomy with a patient-specific cutting guide to treat haemophilic arthritis with severe extra-articular deformity: A case report and review of literatures.全膝关节置换术及使用定制截骨导板的股骨截骨术治疗重度关节外畸形血友病性关节炎：一例报告并文献复习
Front Surg. 2023 Jan 6;9:1067306. doi: 10.3389/fsurg.2022.1067306. eCollection 2022.
9
End Stage Renal Failure Patients With Hemophilia Treated With Peritoneal Dialysis: A Case Series.接受腹膜透析治疗的终末期肾衰竭血友病患者：病例系列
Kidney Int Rep. 2022 Sep 30;7(12):2639-2646. doi: 10.1016/j.ekir.2022.09.030. eCollection 2022 Dec.
10
Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81-8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare setting.药代动力学参数驱动的结局模型预测，与抗血友病因子（重组）血浆/白蛋白游离方法相比，BAY 81-8973 在中国医疗环境中可减少出血事件。
BMC Med Res Methodol. 2022 Aug 5;22(1):215. doi: 10.1186/s12874-022-01659-w.
本文引用的文献
1
How I treat children with haemophilia and inhibitors.我对伴有抑制剂的血友病患儿的治疗方法。
Br J Haematol. 2019 Aug;186(3):400-408. doi: 10.1111/bjh.15942. Epub 2019 May 9.
2
Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients.血友病 A 和 B 的抑制剂：出血管理、抑制剂清除和治疗困难患者的策略。
Eur J Haematol. 2019 Feb;102(2):111-122. doi: 10.1111/ejh.13193. Epub 2018 Dec 6.
3
Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.艾美赛珠单抗预防无抑制剂的血友病 A 患者出血。
N Engl J Med. 2018 Aug 30;379(9):811-822. doi: 10.1056/NEJMoa1803550.
4
Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee.依库珠单抗治疗伴因子 VIII 抑制物的血友病 A 患者出血事件的治疗：英国血友病临床医生组织抑制剂工作组和执行委员会的临时指导意见。
Haemophilia. 2018 May;24(3):344-347. doi: 10.1111/hae.13495.
5
Tailored frequency-escalated primary prophylaxis for severe haemophilia A: results of the 16-year Canadian Hemophilia Prophylaxis Study longitudinal cohort.针对重度甲型血友病的个体化频率递增初级预防：16年加拿大血友病预防研究纵向队列的结果
Lancet Haematol. 2018 Jun;5(6):e252-e260. doi: 10.1016/S2352-3026(18)30048-6. Epub 2018 May 3.
6
Immune tolerance induction: What have we learned over time?免疫耐受诱导：随着时间的推移，我们学到了什么？
Haemophilia. 2018 Apr;24 Suppl 3:3-14. doi: 10.1111/hae.13445.
7
How I manage patients with inherited haemophilia A and B and factor inhibitors.我如何管理患有遗传性甲型和乙型血友病以及因子抑制剂的患者。
Br J Haematol. 2018 Feb;180(4):501-510. doi: 10.1111/bjh.15053. Epub 2017 Dec 22.
8
Emicizumab Prophylaxis in Hemophilia A with Inhibitors.依库珠单抗预防伴抑制物的血友病 A。
N Engl J Med. 2017 Aug 31;377(9):809-818. doi: 10.1056/NEJMoa1703068. Epub 2017 Jul 10.
9
Long-term efficacy and safety of prophylaxis with recombinant factor VIII in Chinese pediatric patients with hemophilia A: a multi-center, retrospective, non-interventional, phase IV (ReCARE) study.重组凝血因子VIII预防治疗中国儿童甲型血友病患者的长期疗效和安全性：一项多中心、回顾性、非干预性IV期（ReCARE）研究
Curr Med Res Opin. 2017 Jul;33(7):1223-1230. doi: 10.1080/03007995.2017.1310720. Epub 2017 Apr 25.
10
When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH.重度血友病无抑制物男孩预防性治疗的起始时间及方式：来自国际血栓与止血学会（ISTH）科学与标准化委员会的沟通
J Thromb Haemost. 2016 May;14(5):1105-9. doi: 10.1111/jth.13298. Epub 2016 Apr 4.
Zotero 插件